Amneal Pharmaceuticals, INC. (AMRX) — DEFA14A Filings

All DEFA14A filings from Amneal Pharmaceuticals, INC.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (2)

Amneal Pharmaceuticals Files DEFA14A Proxy Materials — Apr 22, 2026 Risk: low
Amneal Pharmaceuticals, Inc. filed a DEFA14A on April 22, 2026, related to additional definitive proxy soliciting materials. The filing, with SEC Accession No.
Amneal Pharma Files Additional Proxy Materials on March 25, 2026 — Mar 25, 2026
Amneal Pharmaceuticals, Inc. filed a DEFA14A on March 25, 2026, which are additional definitive proxy soliciting materials. This filing, identified by accession

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX